Laura Whicher Rossetti

Laura Whicher Rossetti has extensive experience in clinical operations, currently serving as Director of Clinical Trial Strategy & Execution at bluebird bio since July 2016, where responsibilities include managing clinical trials and providing monitoring oversight. Previous roles at Sarepta Therapeutics and Biogen Idec included overseeing CROs, preparing key clinical documents, and ensuring compliance with regulations. Laura has a solid foundation in research, having worked as a research assistant at prestigious institutions such as Massachusetts General Hospital and Brigham and Women's Hospital. Laura holds a Bachelor's degree in Biology from UMass Boston and has previously studied at the University of Houston.